1,2,3,5-Tetra-O-acetyl-D-xylofuranose - CAS 30571-56-3
Molecular Formula:
Molecular Weight:
Publictions citing BOC Sciences Products
  • >> More
1.Dataset reporting BCKDK interference in a BCAA-catabolism restricted environment.
Bravo-Alonso I1, Oyarzabal A1, Sánchez-Aragó M2, Rejas MT3, Merinero B1, García-Cazorla A4, Artuch R5, Ugarte M1, Rodríguez-Pombo P1. Data Brief. 2016 Mar 15;7:755-9. doi: 10.1016/j.dib.2016.03.038. eCollection 2016.
This data article contains complementary figures to the research article "Mitochondrial response to the BCKDK-deficiency: some clues to understand the positive dietary response in this form of autism" [1]. Herein we present data relative to the effect of knocking down BCKDK gene on the real time oxygen consumption rate of fibroblasts obtained from a Maple Syrup Urine Disease (MSUD) patient. Interference of BCKDK expression on such cells showing a reduced branched-chain α-ketoacid dehydrogenase (BCKDHc) activity; let us generate a scenario to study the direct effect of BCKDK absence in an environment of high branched-chain amino acids (BCAAs) concentrations. Data relative to the effectiveness of the knockdown together with the potentiality of the BCKDK-knockdown to increase the deficient branched-chain α-ketoacid dehydrogenase activity detected in MSUD patients are also shown.
2.Trends in the consumption of low-calorie sweeteners.
Sylvetsky AC1, Rother KI2. Physiol Behav. 2016 Mar 31. pii: S0031-9384(16)30118-4. doi: 10.1016/j.physbeh.2016.03.030. [Epub ahead of print]
Low-calorie sweeteners (LCS) offer a palatable alternative to caloric sugars such as sucrose (table sugar) and high fructose corn syrup and are commonly found in soft drinks, sweetener packets, grains, snack foods, dairy products, hygiene products, and medications. Consumption of LCS has increased significantly in recent years and while this trend is expected to continue, controversy exists surrounding their use. The purpose of this article is to review trends in the consumption of LCS, to summarize differences in LCS consumption across socio-demographic subgroups and subtypes of LCS-containing products, and to highlight important challenges in the accurate assessment of LCS consumption.
3.Fate of virginiamycin through the fuel ethanol production process.
Bischoff KM1, Zhang Y2, Rich JO3. World J Microbiol Biotechnol. 2016 May;32(5):76. doi: 10.1007/s11274-016-2026-3. Epub 2016 Apr 2.
Antibiotics are frequently used to prevent and treat bacterial contamination of commercial fuel ethanol fermentations, but there is concern that antibiotic residues may persist in the distillers grains coproducts. A study to evaluate the fate of virginiamycin during the ethanol production process was conducted in the pilot plant facilities at the National Corn to Ethanol Research Center, Edwardsville, IL. Three 15,000-liter fermentor runs were performed: one with no antibiotic (F1), one dosed with 2 parts per million (ppm) of a commercial virginiamycin product (F2), and one dosed at 20 ppm of virginiamycin product (F3). Fermentor samples, distillers dried grains with solubles (DDGS), and process intermediates (whole stillage, thin stillage, syrup, and wet cake) were collected from each run and analyzed for virginiamycin M and virginiamycin S using a liquid chromatography-mass spectrometry method. Virginiamycin M was detected in all process intermediates of the F3 run.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Monosaccharides Products

Chemical Structure

CAS 30571-56-3 1,2,3,5-Tetra-O-acetyl-D-xylofuranose

Quick Inquiry

Verification code

Featured Items